Short answer · Medically reviewed summary · Last updated: 2026-04-07
ROHHAD is an acronym for Rapid-onset Obesity with Hypothalamic dysregulation, Hypoventilation, and Autonomic Dysregulation, which remains the primary medical term used by clinicians and researchers. While the condition was historically linked to or confused with Congenital Central Hypoventilation Syndrome (CCHS), ROHHAD is now recognized as a distinct clinical entity, and no other widely accepted synonyms exist in modern medical literature. Why does ROHHAD have multiple names or historical associations? The name ROHHAD is a descriptive acronym that characterizes the complex clinical presentation of this rare disorder.
ROHHAD is an acronym for Rapid-onset Obesity with Hypothalamic dysregulation, Hypoventilation, and Autonomic Dysregulation, which remains the primary medical term used by clinicians and researchers. While the condition was historically linked to or confused with Congenital Central Hypoventilation Syndrome (CCHS), ROHHAD is now recognized as a distinct clinical entity, and no other widely accepted synonyms exist in modern medical literature.
The name ROHHAD is a descriptive acronym that characterizes the complex clinical presentation of this rare disorder. Historically, before the distinct nature of ROHHAD was fully understood, patients were sometimes misdiagnosed with Late-Onset Central Hypoventilation Syndrome or Late-Onset CCHS. Because the symptoms, particularly the hypoventilation, share surface-level similarities with CCHS, early medical records may reflect this confusion. However, the medical community now strictly distinguishes ROHHAD from CCHS due to the specific hypothalamic and autonomic involvement, as well as the later age of onset, which typically occurs after age 1.5 to 2 years.
In medical classification systems, ROHHAD is identified by its descriptive name rather than a numbered code alone. Because it is an extremely rare condition, it is categorized under specific rare disease databases that help physicians track clinical data globally:
Across international medical traditions, ROHHAD is the standard terminology. There are no regional synonyms or traditional names used in other languages; the acronym is universally adopted in English-language research papers and clinical guidelines. When searching for literature or clinical trials, medical professionals exclusively use the term ROHHAD or the full phrase: Rapid-onset Obesity with Hypothalamic dysregulation, Hypoventilation, and Autonomic Dysregulation. Using this exact name ensures that patients and caregivers retrieve the most accurate and up-to-date peer-reviewed information.
In recent years, you may encounter the term ROHHAD-NET. This refers to the association between ROHHAD and Neural Crest Tumors (NETs). Because a significant subset of children with this condition develop ganglioneuromas or other neural crest tumors, researchers often use the expanded term ROHHAD-NET to emphasize the critical need for oncological screening in these patients. This is not a different disease, but rather an evolution in terminology to ensure that the risk of tumors is highlighted as a core component of the syndrome’s management.
Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition.